Literature DB >> 16132494

Subacute cerebellar degeneration associated with calcitonin producing tumor.

Damir Petravić, Mario Habek, Zdravko Perković, Jasna Franjić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16132494     DOI： 10.1007/s11060-005-4571-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  11 in total

1.  Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer.

Authors:  P J Lamy; J Grenier; A Kramar; J L Pujol
Journal:  Lung Cancer       Date:  2000-09       Impact factor: 5.705

2.  Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.

Authors:  M E Sunday; N Choi; E R Spindel; W W Chin; E J Mark
Journal:  Hum Pathol       Date:  1991-10       Impact factor: 3.466

Review 3.  Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.

Authors:  K-Y Lam; C-Y Lo
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

Review 4.  The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.

Authors:  G A Kaltsas; J J Mukherjee; A B Grossman
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

5.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

6.  Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.

Authors:  Y Miyake; T Kodama; K Yamaguchi
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

7.  Pro-gastrin-releasing peptide in patients with benign and malignant diseases.

Authors:  Rafael Molina; Jose M Auge; Julian Alicarte; Xavier Filella; Nuria Viñolas; Antonio M Ballesta
Journal:  Tumour Biol       Date:  2004 Jan-Apr

8.  Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

Authors:  Rossella Elisei; Valeria Bottici; Fabiana Luchetti; Giancarlo Di Coscio; Cristina Romei; Lucia Grasso; Paolo Miccoli; Pietro Iacconi; Fulvio Basolo; Aldo Pinchera; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

9.  Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.

Authors:  Joachim Schneider; Monika Philipp; Hans-Georg Velcovsky; Harald Morr; Norbert Katz
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

10.  Calcitonin elevation in small cell lung cancer without ectopic production.

Authors:  M J Kelley; K L Becker; J M Rushin; D Venzon; R Phelps; D C Ihde; D P Bliss; K Melby; R H Snider; B E Johnson
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.